I was talking to an HME provider on the phone yesterday, which I’m known to do, and he mentioned a guest blog that we posted to our website recently in which a provider makes the case for allowing competitive bidding to move forward a
WASHINGTON – With a new bill for the market-pricing program (MPP) expected to drop soon, industry stakeholders are mulling another legislative tactic in the fight against competitive bidding: a delay in the implementation of Round 2.
WASHINGTON – Taking the “blunt ax” of competitive bidding to home infusion drugs is the wrong way to reduce costs, say stakeholders, but in February, the Office of Inspector General (OIG) recommended CMS do just that.
The overwhelming question that came to everyone’s mind after the latest single payment amounts (SPAs) were released for Round 2 of competitive bidding was: “What do we do now?” Pundits and providers alike were shocked that the SPAs came in so low.
I would consider this a logical argument: 1.) Our population is aging. 2.) That population would prefer to stay in the home as long as possible. 3.) Because of this, the demand for home medical equipment will increase.